Deficiency

(redirected from Biotinidase deficiency)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.

Deficiency

A shortage or insufficiency. The amount by which federal Income Tax due exceeds the amount reported by the taxpayer on his or her return; also, the amount owed by a taxpayer who has not filed a return. The outstanding balance of a debt secured by a mortgage after the mortgaged property has been sold to satisfy the obligation at a price less than the debt.

References in periodicals archive ?

AutoDELFIA tests: Galactosemia, Biotinidase deficiency, Cystic fibrosis, Hypothyroidism, Congenital Adrenal Hyperplasia.

Newborn screening program for Oman: the time is here and now

Biotinidase deficiency has an inexpensive and reliable screening test, it is easily treatable and has a high morbidity and mortality in untreated cases.

Biotinidase deficiency in Pakistani children; what needs to be known and done

Biotinidase deficiency and galactosemia cannot be screened by tandem mass spectrometry.

Newborn screening in the 21st century: current status and considerations: a white paper from the Health Promotion and Prevention Committee, American Association on Mental Retardation, June 7, 2002

In July, the state added newborn screening for biotinidase deficiency, congenital adrenal hyperplasia (CAH), cystic fibrosis, and maple syrup urine disease.

CARES Foundation, Inc. (organizational spotlight)

It is noteworthy that a small fraction of infants with biotinidase deficiency will have increased C50H.

Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns

The nine mandated disorders are biotinidase deficiency, congenital adrenal hyperplasia, hypothyroidism, hemoglobinopathies, toxoplasmosis, galactosemia, phenylketonuria (PKU), maple syrup urine disease (MSUD), and homocystinuria (HCU).

Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England newborn screening program

Ongoing research in disciplines including cell biology, biochemistry, enzymology and genetics (aided by increasing sophistication of techniques such as electron microscopy, chromatography, and spectrophotometry) enabled development of tests for congenital hypothyroidism, biotinidase deficiency, congenital adrenal hyperplasia, and hemoglobinopathies such as sickle cell disease.